Investing in research means securing a healthy future for the world. Our Research & Development department is to develop innovative, high quality, cost effective and safe processes for generic molecules as well as provide life cycle management for existing molecules for global customers as well as domestic.
Assurgen has an impeccable track record of delivering active pharmaceutical ingredients (APIs), and intermediates to global customers with outmost confidentiality. Our facility was built to meet the specific needs of customers and stringent requirements of the advanced markets such as EMEA (Europe, South Africa, Russia), APAC (Japan and Australia), LATAM (Mexico and Brazil) and Canada.
Assurgen R&D provides the impetus in our journey to attain leadership in APIs, complex generics and specialty therapeutics. Our research and development capabilities have kept us in the forefront of new product development. Emphasis on being the first-to-market and fast- to-market, benefiting our patients, partners and associates.
Our comprehensive environment, health and safety (EHS) policy ensures that the interests of all constituents are safeguarded. Processes are developed at our R&D with significant focus on process understanding with a view to increasing yield and throughput as also on optimization of effluent treatability processes. We also focus on waste treatability as part of our development projects.